Anthrax Vaccine Market Report 2026
Download Free Sample Buy Now
Anthrax Vaccine Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Anthrax Vaccine Market Report 2026

Global Outlook – By Vaccine Type (Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine), By Application Type (Animal Use, Human Use), By Distribution Channel (Hospitals, Pharmacies, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anthrax Vaccine Market Overview

• Anthrax Vaccine market size has reached to $11.77 billion in 2025

• Expected to grow to $14.49 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%

• Growth Driver: Rising Infectious Diseases Fueling Growth In The Anthrax Vaccine Market

• Market Trend: Advancements And FDA Approvals In The Anthrax Vaccine Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anthrax Vaccine Market?

The anthrax vaccine is a medical product designed to provide immunity against anthrax, a severe infectious disease caused by the bacterium Bacillus anthracis. The vaccine comprises an inactivated form of the anthrax bacterium or its components, stimulating the body's immune system to produce antibodies against anthrax toxins. The anthrax vaccine is typically administered through injections, with initial doses followed by booster shots to maintain immunity over time.

The main vaccine types of the anthrax vaccine are the cell-free protective antigen (PA) vaccine and the live attenuated vaccine. A cell-free protective antigen (PA) vaccine is made in a lab without the use of live bacteria by synthesizing the anthrax bacteria's protective antigen (PA) protein. The applications include animal and human use, and they are distributed through various channels such as hospitals, pharmacies, and others.

Anthrax Vaccine Market Global Report 2026 Market Report bar graph

What Is The Anthrax Vaccine Market Size and Share 2026?

The anthrax vaccine market size has grown steadily in recent years. It will grow from $11.77 billion in 2025 to $12.33 billion in 2026 at a compound annual growth rate (CAGR) of 4.7%. The growth in the historic period can be attributed to high prevalence of anthrax in livestock, government-led vaccination campaigns, research in immunology, limited vaccine production capacity, increased awareness of occupational exposure.

What Is The Anthrax Vaccine Market Growth Forecast?

The anthrax vaccine market size is expected to see steady growth in the next few years. It will grow to $14.49 billion in 2030 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to development of recombinant and next-generation vaccines, rising demand for human and animal prophylaxis, advancements in vaccine delivery technologies, expansion of biodefense programs, collaborations between pharma and defense sectors. Major trends in the forecast period include advanced vaccine formulations, expanded immunization programs, cold chain & storage innovations, biodefense & pandemic preparedness, government & military vaccination initiatives.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Anthrax Vaccine Market Segmentation

1) By Vaccine Type: Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine

2) By Application Type: Animal Use, Human Use

3) By Distribution Channel: Hospitals, Pharmacies, Other Distribution Channels

Subsegments:

1) By Cell-Free Protective Antigen (PA) Vaccine: Recombinant Protective Antigen (rPA) Vaccine, Adjuvanted rPA Vaccine

2) By Live Attenuated Vaccine: Live Attenuated Bacillus anthracis Vaccine, Genetically Modified Live Attenuated Vaccine

What Is The Driver Of The Anthrax Vaccine Market?

The rising prevalence of infectious diseases is expected to propel the growth of the anthrax vaccine market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi, which can spread directly or indirectly from one person to another, often leading to symptoms ranging from mild to severe and sometimes fatal, depending on the pathogen and the individual's immune response. The prevalence of infectious diseases is due to shifts in the demographics of the world's population, urbanization, changes in the environment and land use, and changes in human behavior. The anthrax vaccine is primarily utilized to protect against anthrax, and its potential for broader use in preventing other infectious diseases is being explored through research into its immunogenic properties and adaptability. For instance, in February 2023, according to the Council on Foreign Relations, a US-based nonprofit organization, up to 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases had zoonotic origins. Further, worldwide, zoonoses cause 2.7 million human fatalities and 2.5 billion episodes of disease in people each year. Therefore, the rising prevalence of diseases is driving the growth of the anthrax vaccine industry.

Key Players In The Global Anthrax Vaccine Market

Major companies operating in the anthrax vaccine market are Emergent BioSolutions Inc., Indian Immunologicals Limited, GC Biopharma, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company Inc., Botswana Vaccine Institute, VECOL S.A., Biological E Limited, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., China National Biotec Group, Sinovac Biotech Ltd., Instituto Butantan, Razi Vaccine and Serum Research Institute, Federal State Unitary Enterprise Microgen, KM Biologics Co. Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd.

Global Anthrax Vaccine Market Trends and Insights

Major companies operating in the anthrax vaccine market are focused on developing innovative products and getting FDA approvals for their vaccines to ensure safety, efficacy, and availability to those at risk of exposure to anthrax. FDA approval ensures the vaccine is rigorously tested in clinical trials and proven safe for public use. This helps protect individuals from potential adverse effects. For instance, in July 2023, Emergent BioSolutions Inc., a US-based biopharmaceutical company, received approval for CYFENDUS (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, from the U.S. Food and Drug Administration (FDA). The approval was predicated on information from a Phase 2 trial evaluating Cyfendus's non-interference with antibacterial medications and Phase 3 clinical research comparing the immunogenicity and safety of the vaccine to BioThrax, the previous anthrax vaccine. Further, developing safer and more effective adjuvants is imperative to address reactogenicity-related problems and enhance the general efficiency of anthrax vaccines.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Anthrax Vaccine Market?

In April 2025, Green Cross Corporation, a South Korea-based biopharmaceutical company that develops anthrax and other vaccines and biologics, partnered with the Korea Disease Control and Prevention Agency (KDCA) for the development and approval of a recombinant anthrax vaccine. With this partnership, GC Biopharma and KDCA aim to leverage their respective expertise in biotechnology and public health, combining GC Biopharma’s recombinant-protein vaccine technology with KDCA’s regulatory and disease prevention capabilities to provide a safe and effective anthrax vaccine, ultimately strengthening national biodefense preparedness. Korea Disease Control and Prevention Agency (KDCA) is a South Korea-based government agency responsible for disease control, prevention, and public health management.

Regional Insights

North America was the largest region in the anthrax vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anthrax Vaccine Market?

The anthrax vaccine market consists of sales of avirulent, nonencapsulated bacillus anthracis microaerophilic cultures, aluminum, benzethonium chloride, and formaldehyde. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Anthrax Vaccine Market Report 2026?

The anthrax vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anthrax vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Anthrax Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $12.33 billion
Revenue Forecast In 2035 $14.49 billion
Growth Rate CAGR of 4.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Vaccine Type, Application Type, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Emergent BioSolutions Inc., Indian Immunologicals Limited, GC Biopharma, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company Inc., Botswana Vaccine Institute, VECOL S.A., Biological E L
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Anthrax Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Anthrax Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Anthrax Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Anthrax Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Advanced Vaccine Formulations

4.2.2 Expanded Immunization Programs

4.2.3 Cold Chain & Storage Innovations

4.2.4 Biodefense & Pandemic Preparedness

4.2.5 Government & Military Vaccination Initiatives

5. Anthrax Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Pharmacies

5.3 Military & Defense Agencies

5.4 Veterinary Clinics

5.5 Public Health Organizations

6. Anthrax Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anthrax Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anthrax Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Anthrax Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Anthrax Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Anthrax Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anthrax Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anthrax Vaccine Market Segmentation

9.1. Global Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine

9.2. Global Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Animal Use, Human Use

9.3. Global Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Pharmacies, Other Distribution Channels

9.4. Global Anthrax Vaccine Market, Sub-Segmentation Of Cell-Free Protective Antigen (PA) Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Protective Antigen (rPA) Vaccine, Adjuvanted rPA Vaccine

9.5. Global Anthrax Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Live Attenuated Bacillus anthracis Vaccine, Genetically Modified Live Attenuated Vaccine

10. Anthrax Vaccine Market Regional And Country Analysis

10.1. Global Anthrax Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Anthrax Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anthrax Vaccine Market

11.1. Asia-Pacific Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anthrax Vaccine Market

12.1. China Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anthrax Vaccine Market

13.1. India Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anthrax Vaccine Market

14.1. Japan Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anthrax Vaccine Market

15.1. Australia Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anthrax Vaccine Market

16.1. Indonesia Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anthrax Vaccine Market

17.1. South Korea Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anthrax Vaccine Market

18.1. Taiwan Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anthrax Vaccine Market

19.1. South East Asia Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anthrax Vaccine Market

20.1. Western Europe Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anthrax Vaccine Market

21.1. UK Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anthrax Vaccine Market

22.1. Germany Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anthrax Vaccine Market

23.1. France Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anthrax Vaccine Market

24.1. Italy Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anthrax Vaccine Market

25.1. Spain Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anthrax Vaccine Market

26.1. Eastern Europe Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anthrax Vaccine Market

27.1. Russia Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anthrax Vaccine Market

28.1. North America Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anthrax Vaccine Market

29.1. USA Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anthrax Vaccine Market

30.1. Canada Anthrax Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anthrax Vaccine Market

31.1. South America Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anthrax Vaccine Market

32.1. Brazil Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anthrax Vaccine Market

33.1. Middle East Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anthrax Vaccine Market

34.1. Africa Anthrax Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Anthrax Vaccine Market, Segmentation By Vaccine Type, Segmentation By Application Type, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anthrax Vaccine Market Regulatory and Investment Landscape

36. Anthrax Vaccine Market Competitive Landscape And Company Profiles

36.1. Anthrax Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Anthrax Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Anthrax Vaccine Market Company Profiles

36.3.1. Emergent BioSolutions Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Indian Immunologicals Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. GC Biopharma Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Valneva SE Overview, Products and Services, Strategy and Financial Analysis

36.3.5. PharmAthene Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Anthrax Vaccine Market Other Major And Innovative Companies

Porton Biopharma Limited, Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company Inc., Botswana Vaccine Institute, VECOL S.A., Biological E Limited, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., China National Biotec Group, Sinovac Biotech Ltd., Instituto Butantan, Razi Vaccine and Serum Research Institute, Federal State Unitary Enterprise Microgen, KM Biologics Co. Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd.

38. Global Anthrax Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anthrax Vaccine Market

40. Anthrax Vaccine Market High Potential Countries, Segments and Strategies

40.1 Anthrax Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Anthrax Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Anthrax Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Anthrax Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Anthrax Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Anthrax Vaccine Market, Supply Chain Analysis
  • Table 4: Global Anthrax Vaccine Market, Major Raw Material Providers
  • Table 5: Global Anthrax Vaccine Market, Major Resource Providers
  • Table 6: Global Anthrax Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Anthrax Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Anthrax Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Anthrax Vaccine Market, Major Trends
  • Table 10: Global Anthrax Vaccine Market, Major End Users
  • Table 11: Global Anthrax Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Anthrax Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Anthrax Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Anthrax Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Anthrax Vaccine Market, Sub-Segmentation Of Cell-Free Protective Antigen (PA) Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Anthrax Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Anthrax Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Anthrax Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Anthrax Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Anthrax Vaccine Market - Company Scoring Matrix
  • Table 96: Emergent BioSolutions Inc. Financial Performance
  • Table 97: Indian Immunologicals Limited Financial Performance
  • Table 98: GC Biopharma Financial Performance
  • Table 99: Valneva SE Financial Performance
  • Table 100: PharmAthene Inc. Financial Performance
  • Table 101: Global Anthrax Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Anthrax Vaccine Market, Competitive Dashboard
  • Table 103: Global Anthrax Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 105: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Application Type, 2025 – 2030
  • Table 106: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

    Figure 1: Global Anthrax Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Anthrax Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Anthrax Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Anthrax Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Anthrax Vaccine Market, Major Resource Providers
  • Figure 6: Global Anthrax Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Anthrax Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Anthrax Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Anthrax Vaccine Market, Major Trends
  • Figure 10: Global Anthrax Vaccine Market, Major End Users
  • Figure 11: Global Anthrax Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Anthrax Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Anthrax Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Anthrax Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Anthrax Vaccine Market, Sub-Segmentation Of Cell-Free Protective Antigen (PA) Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Anthrax Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Anthrax Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Anthrax Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Anthrax Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Anthrax Vaccine Market, Segmentation By Application Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Anthrax Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Anthrax Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Anthrax Vaccine Market - Company Scoring Matrix
  • Figure 96: Emergent BioSolutions Inc. Financial Performance
  • Figure 97: Indian Immunologicals Limited Financial Performance
  • Figure 98: GC Biopharma Financial Performance
  • Figure 99: Valneva SE Financial Performance
  • Figure 100: PharmAthene Inc. Financial Performance
  • Figure 101: Global Anthrax Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Anthrax Vaccine Market, Competitive Dashboard
  • Figure 103: Global Anthrax Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 105: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Application Type, 2025 – 2030
  • Figure 106: Global, Anthrax Vaccine Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Industry Trends Show Gene Synthesis Market Set to Expand at 21.2% CAGR Until 2029

Read More About Industry Trends Show Gene Synthesis Market Set to Expand at 21.2% CAGR Until 2029

Strategic Report on Generic Injectables Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Generic Injectables Market: Growth Opportunities and Emerging Challenges

Key Market Drivers, Trends, and Forecast for the Global Generic Oncology Drugs Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Generic Oncology Drugs Industry

Outlook for Grand Mal Seizure Treatment Market: Key Developments and Future Strategies to 2029

Read More About Outlook for Grand Mal Seizure Treatment Market: Key Developments and Future Strategies to 2029

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

UV Disinfection Equipment Market Report 2026 - Global Outlook – By Component (UV Lamp, Controller Unit, Quartz Sleeve, Reactor Chamber, Other Components ), By Power Rating (Low, Medium, High ), By Application (Water Trea...

Entertainment Buildings Market Report 2026 - Global Outlook – By Type (Residential, Non-residential), By Construction Type (New Construction, Renovation), By Application (Owned, Rental), By End User (Private, Public) – M...

Erdheim Chester Disease Market Report 2026 - Global Outlook – By Treatment (Chemotherapy, Immunotherapy, Radiation Therapy, Other Treatments), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations)...

Underwater Drone Market Report 2026 - Global Outlook – By Vehicle Control Mode (Remotely Operated Vehicle, Autonomous Underwater Vehicles, Hybrid Vehicles), By Product Type (Micro, Small And Medium, Light Work-Class, Hea...

Polymerase Chain Reaction (PCR) Technologies Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments, Software, Services), By Technology (Real-Time Polymerase Chain Reaction, Conventional ...

Polymerase Chain Reaction (PCR) Technologies Market Report 2026 - Global Outlook – By Product (Reagents And Consumables, Instruments, Software, Services), By Technology (Real-Time Polymerase Chain Reaction, Conventional ...

Automotive Stainless Steel Market Report 2026 - Global Outlook – By Tube Type (Straight Tubes, U-Bends, Coiled Tubes), By Manufacturing Method (Seamless Tubes, Welded Tubes), By Vehicle Type (Passenger Cars, Commercial V...

Frequently Asked Questions

The Anthrax Vaccine market was valued at $11.77 billion in 2025, increased to $12.33 billion in 2026, and is projected to reach $14.49 billion by 2030.

The global Anthrax Vaccine market is expected to grow at a CAGR of 4.1% from 2026 to 2035 to reach $14.49 billion by 2035.

Some Key Players in the Anthrax Vaccine market Include, Emergent BioSolutions Inc., Indian Immunologicals Limited, GC Biopharma, Valneva SE, PharmAthene Inc., Porton Biopharma Limited, Choong Ang Vaccine Laboratories Co. Ltd., Colorado Serum Company I

Major trend in this market includes: Advancements And FDA Approvals In The Anthrax Vaccine Market. For further insights on this market. request a sample here

North America was the largest region in the anthrax vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anthrax vaccine market report are Asia-Pacific, South Ea

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us